Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHART: Artesunate vs Quinine for Late Post-treatment Anaemia in Malaria
NCT02092766Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jun 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of artesunate in Plasmodium falciparum malaria (2 arms), sponsored by University of Oxford. Primary endpoint: Late onset anaemia. Started Jun 2014; status: completed.
02
Drugs
artesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02092766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092766.